Navigation Links
AdMeTech to Testify in Congress About Prostate Cancer Crisis, Research to Improve Diagnostic Tools as a Solution
Date:3/1/2010

Health Care Reform Highlights Need for Better Screening and Prevention

Foundation for Improving Prostate Imaging Technology Praises House Committee for Hearing

WASHINGTON, March 1 /PRNewswire-USNewswire/ -- AdMeTech Foundation announced today that its President and CEO Dr. Faina Shtern will testify on March 4 before the U.S. House Committee on Oversight and Government Reform on how health care reform highlights the need for increased funding for research aimed at creating accurate, life-saving diagnostic tools for prostate cancer, which will improve screening, prevention, early detection and reduce health costs.

Dr. Shtern, a leader over the past 20 years in the development of advanced breast cancer imaging and other technologies, will testify that the development of accurate diagnostic tools is critical for ending prostate cancer crisis in this country. She praised Chairman Ed Towns (D-NY), Committee Ranking Member Darrell Issa (R-CA), and Rep. Elijah Cummings (D-MD) for bringing prostate cancer issues, such as diagnosis, treatment and a disproportionate impact on African American men, to the national stage.

"The primary goal of health care reform is to guarantee access to high quality health care for millions of Americans while reducing health costs through improved screening, prevention and early detection. However, current diagnostic tools for prostate cancer are so unreliable that they lead to a compromised quality of life in millions of men and add billions of dollars to health care costs," Dr. Shtern said. "The hearing on March 4 is a great step toward recognition of the prostate cancer crisis on Capitol Hill."

Prostate cancer is the most common major cancer in the United States and the second most lethal cancer in men. A man is diagnosed every 2.5 minutes, and the incidence has increased seven fold in men aged 50 and younger, and tripled in men aged 50 to 59 since 1986. A man dies every 19 minutes from prostate cancer, even though prostate cancer can be cured when detected early.

Existing prostate diagnostics, such as prostate specific antigen (PSA) biomarker and digital rectal exam cause widespread underdiagnosis, overdiagnosis and overtreatment, with dire human and societal costs. Current diagnostics miss and/or underestimate the extent or aggressiveness of prostate cancer and lead to treatment failures in as many as half of all men. False diagnostic alarms result in a staggering extent of unnecessary biopsies and treatment, costing billions of dollars each year. Up to 88 percent of all biopsies – performed on more than 1 million men blindly and randomly each year – do not show prostate cancer. As many as 54 percent of men with early prostate cancer undergo unnecessary treatment and are left with life-altering complications, such as incontinence and impotence. Improved diagnostic tools, including more specific versions of biomarkers and advanced imaging tools to guide biopsies and treatment, will save lives, enable the least invasive and the most effective patient care, reduce unnecessary procedures, and decrease health care costs.

AdMeTech Foundation is a nonprofit organization with the mission to end the prostate cancer crisis. AdMeTech provides international leadership and conducts ground-breaking programs in research and education to facilitate development of accurate diagnostic tools for early detection and minimally-invasive treatment of prostate cancer. For more information, log onto www.admetech.org.

SOURCE AdMeTech Foundation

Back to top
'/>"/>
SOURCE AdMeTech Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
3. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
4. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
5. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
6. Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
7. Genasense(R) Data in Patients with Advanced Melanoma to be Featured at 4th International Melanoma Congress
8. Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health
9. Congressional Funds Awarded for Testing of Antimicrobial Copper Metals
10. Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the OARSI 2007 World Congress on Osteoarthritis
11. New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)...   Plexus Technology Group, LLC (Plexus ... systems (AIMS), is pleased to announce the addition ... of Technology. In this new capacity, Mr. Marcey ... company,s technological development. He will collaborate with each ... expansion of new products, product features and enhancements.  ...
(Date:5/31/2016)... York , May 31, 2016 ... essential ingredient in food, cosmetics and pharmaceuticals, with global ... revenues worth US$ 1.6 Bn. Demand for ... products, juices, and yogurts will continue its upward momentum ... trend will also boost positive sentiment on aloe vera, ...
(Date:5/31/2016)... Israel , May 31, 2016 ... its proprietary plant-based rhCollagen technology for tissue repair products ... Chief Scientist of Israel,s Ministry ... 12 million development project for 2016. The Chief Scientist,s grant ... year,s authorized grant, which totaled NIS 4.7 million.  ...
Breaking Medicine Technology:
(Date:5/31/2016)... London, Ontario (PRWEB) , ... May 31, 2016 , ... ... more than 2,000 clients already know – London is home to Ontario’s leading day ... and direction of visionary Fayez Tamba began with a unique concept to combine spa ...
(Date:5/31/2016)... ... , ... In his latest video, renowned AstroNumerologist Jesse Kalsi ... presidential candidate Donald Trump as an example, Kalsi describes the way AstroNumerology conveys ... adding numbers up,” says Kalsi. “It is about looking at each individual number, ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Interest is on ... screening tool and as an orthogonal tool for RNAi hit validation. A key reason ... specific guide RNAs—allows rapid generation of CRISPR RNA (crRNA) collections in arrayed formats. ...
(Date:5/31/2016)... ... ... In a recent interview on The Greenburgh Report radio show hosted by Greenburgh, NY ... AM), leading medical insurance advocate Adria Goldman Gross discussed several eye-opening issues that have ... During the interview with Mr. Feiner that aired on May 7, 2016, Ms. Gross, ...
(Date:5/31/2016)... Chicago, IL (PRWEB) , ... May 31, 2016 ... ... industry-leading multichannel marketing services firm and statement solutions provider, for the ... released in the May 2016 issue of Advertising Age, and SourceLink ranked eighteenth ...
Breaking Medicine News(10 mins):